Blood test boosts cancer detection sixfold

A preliminary blood test called "Galleri" has shown a significantly greater ability to detect multiple types of cancer compared to current routine screenings, identifying over six times more cancers. The study included approximately 35,878 individuals in the United States and Canada, revealing that the test detected cancers at early stages such as stages I and II in 53% of cases, and accurately pinpointed the tumor location in over 90% of cases. However, the results indicate that this technology is not yet a replacement for existing tests and should be considered an additional tool to expand detection, especially for cancers that are not accessible through routine screening, such as pancreatic, liver, and ovarian cancers, for which early detection has not yet been proven to reduce mortality rates.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل